LinkedIn | Twitter | ORCiD | Google Scholar  | Web of Science | Scopus

Qualifications:

  • B.Sc (Hons) (1988) and PhD (1993), University of Melbourne
  • MBA (2017), University of Queensland

Current roles:

  • Director, MSBChem Consulting, Brisbane-based with worldwide reach (since Jan 2020)
  • Chief Scientific Officer, AIA Insights, Birmingham, UK & Brisbane, Australia (since May 2022)
  • Casual Academic, Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (since May 2022)

Previous roles:

  • Adjunct Associate Professor, Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (Apr 2020 → May 2022)
  • Consultant, Global Action Plan on Antimicrobial Resistance, World Health Organization, Geneva, Switzerland (Apr 2020 → Feb 2022)
  • Technical Officer (Part-time), BioCifer Pty Ltd, Sunshine Coast/Brisbane, Australia (Feb 2021 → Mar 2022)
  • Principal Research Fellow, UQ Centre for Clinical Research, University of Queensland, Brisbane, Australia (Mar 2018 → Dec 2019)
  • Senior Research Fellow Grade 2, Institute for Molecular Bioscience, University of Queensland, Brisbane, Australia (Sep 2009 → Dec 2017)
  • Director Natural Product Chemistry, MerLion Pharmaceuticals, Singapore (May 2002 → Aug 2009)
  • Adjunct Associate Professor, Department of Chemistry, National University of Singapore, Singapore (Feb 2006 → Aug 2009)
  • Research Leader, Centre for Natural Product Research, Singapore (Nov 1999 → Apr 2002)
  • Team Leader, Queensland Pharmaceutical Research Institute, Griffith University, Brisbane, Australia (Jan 1999 → Sep 1999)
  • Research Fellow, Queensland Pharmaceutical Research Institute, Griffith University, Brisbane, Australia (Oct 1994 → Dec 1998)
  • Postdoctoral Research Associate, Cancer Research Institute, Arizona State University, Tempe, USA (Jan 1993 → Sep 1994)